IMVT EBITDA Margin

Immunovant Inc · EBITDA Margin

IMVT logo

IMVT EBITDA Margin

Latest reported-7590.15%
IMVT TTM EBITDA Margin (-7590.15% → -7590.15%)
More history is needed to export this chart.

IMVT ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Immunovant Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-7,590.148%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.